Medically reviewed by Dr. Shweta Agarwal, MBBS, DGO. Last updated: June 2026.
Information on this page is educational and does not replace a medical consultation. Individual findings and next steps depend on clinical factors.
Follicular monitoring is sometimes called फॉलिक्युलर मॉनिटरिंग in Marathi — the same serial ultrasound assessment used to confirm that developing follicles are on track, that the uterine lining is building appropriately, and that the moment of egg release or retrieval can be identified with precision. It is a monitoring and timing tool, not a fertility assessment or pregnancy test, and it is performed in-house at our Chandrapur facility. You can verify our ART registration on the National ART & Surrogacy Registry.
What exactly does a follicular monitoring scan measure, and why does each measurement matter?
Every follicular monitoring scan captures two key pieces of information that directly guide your treatment cycle. First, the follicle assessment: the scan counts the number of follicles developing in each ovary and measures the diameter of each one. Follicles are fluid-filled sacs, each containing a developing egg. As a cycle progresses under natural or stimulated conditions, one or more follicles grow — typically at around 1–2 mm per day during the active growth phase. When the lead follicle reaches approximately 18–20 mm in diameter, the egg inside is considered mature and ready for ovulation or retrieval. Second, the endometrial assessment: the thickness and pattern (texture) of the uterine lining is measured on the same scan. A lining that is thickening appropriately — towards 8 mm or more with a characteristic triple-layer pattern — indicates that the uterus is preparing well for the arrival of a fertilised egg. If the lining is thinner than expected, the team may discuss additional lining support or a change in medication. In stimulated cycles, blood oestradiol (E2) measurements are sometimes added alongside the ultrasound to assess the hormonal dimension of follicle development, particularly when injectable gonadotropins are being used.
In which treatment cycles is follicular monitoring needed, and what does it guide in each?
Follicular monitoring is used across several different treatment pathways, but its role in each is distinct. In an ovulation induction cycle — where medication such as letrozole, clomiphene, or injectable gonadotropins is used to encourage the ovaries to develop follicles — monitoring confirms that the medication is working as intended and allows the dose to be adjusted if the response is too weak or too strong. It also identifies the moment to give the trigger injection (hCG), which prompts final egg maturation and ovulation approximately 36–38 hours later, so that intercourse or insemination can be timed to the fertile window. In an IUI (intrauterine insemination) cycle, follicular monitoring serves the same purpose — confirming follicle development and triggering at the right moment so that insemination is scheduled to coincide with ovulation. In an IVF stimulation cycle, monitoring takes on an additional role: because the aim is to develop multiple follicles simultaneously, scans every 2–3 days throughout the stimulation phase allow the clinical team to track individual follicle sizes across both ovaries, adjust the gonadotropin dose in real time, identify any follicle developing significantly faster or slower than the rest, and time the trigger shot so that retrieval is scheduled 34–36 hours later — consistent with the stimulation protocol. Follicular monitoring is also used in natural (un-medicated) cycles for couples who benefit from knowing the precise fertile window without taking ovulation-stimulating medication.
What does a typical monitoring scan schedule look like across a cycle?
The schedule varies by cycle type and individual response, but the general pattern is consistent. A baseline scan is performed early in the cycle — typically on Day 2 or 3 — to confirm that the ovaries are in a resting state, that there is no residual cyst from a previous cycle, and to establish the starting antral follicle count. This scan determines whether it is safe to begin medication. Monitoring scans then begin around Day 10–12, when follicles in a stimulated cycle would be expected to have grown to a size at which progress can be assessed. From that point, scans are repeated approximately every 2–3 days, with the interval shortening as follicles approach maturity, since daily growth accelerates. Once the lead follicle reaches approximately 18–20 mm, the decision to trigger is made. In ovulation induction and IUI cycles, the number of monitoring visits varies by individual response; IVF stimulation cycles generally require more frequent visits because multiple follicles of varying sizes must all be tracked simultaneously. The clinical team reviews each scan result the same day and advises on the next step.
How does the monitoring result influence dose adjustments and cycle decisions?
The power of follicular monitoring lies in what the data enables the clinical team to do between scans. If follicles are growing more slowly than expected, the gonadotropin dose can be increased to drive a better response. If follicles are growing faster, or if too many follicles are developing at once, the dose can be reduced — or, if the risk of ovarian hyperstimulation syndrome (OHSS) or high-order multiple pregnancy is unacceptable, the cycle can be converted or cancelled before the trigger injection is given. OHSS is an exaggerated response to stimulation in which the ovaries become enlarged and fluid accumulates abnormally; women with PCOS or a high antral follicle count are at increased risk, and monitoring is the mechanism by which this risk is identified early enough to act. Conversely, if monitoring reveals a poor response — very few or very slowly growing follicles despite adequate medication — the team can make a clinical assessment about whether proceeding, adjusting the protocol, or cancelling the cycle is the right decision. In IVF cycles, the combination of follicle sizes and oestradiol levels across multiple scan visits also informs the specific timing of the trigger so that egg retrieval is scheduled precisely 34–36 hours later, maximising the number of mature eggs collected. Every dose change, cycle decision, and timing call is made using real data from your scans — not a fixed calendar.
What is the scan itself like? Is it uncomfortable?
A follicular monitoring scan uses transvaginal ultrasound (TVS). A slim, purpose-designed ultrasound probe is gently inserted into the vagina; the ovaries and uterus become visible on-screen within seconds, providing a clear, close-up view that is not possible with an abdominal scan when the ovaries are the focus. The scan requires no anaesthesia and no sedation. Most patients describe the sensation as mild pressure; significant pain is not typical. The bladder should be empty or only mildly full — unlike the full-bladder preparation required for an abdominal obstetric scan. The scanning portion of the appointment takes approximately 5–10 minutes. Results are reviewed with you by Dr. Shweta Agarwal and the next step in the cycle is advised at the same visit or on the same day. If you have a history of pelvic discomfort or sensitivity, let the team know before the scan so the appointment can be managed accordingly.
What does follicular monitoring not do? (Important boundaries)
Follicular monitoring is a cycle-timing and response-tracking tool. It is not the same as an ovarian reserve assessment, and it does not measure your overall egg supply or long-term fertility potential. If you want to understand your ovarian reserve — the number of follicles available in your ovaries as a measure of egg supply — that requires an AMH (anti-Müllerian hormone) blood test and antral follicle count assessment, which is a separate investigation performed outside of a treatment cycle. Follicular monitoring during a cycle tells you how the follicles present in that cycle are growing and when they are ready — it does not predict how many follicles would be available in future cycles or provide a fertility diagnosis. Similarly, follicular monitoring is not a pregnancy test; it confirms follicle development and ovulation, not whether fertilisation or implantation has occurred. A complete fertility assessment should precede treatment planning so that the right cycle type and monitoring intensity are chosen for your specific clinical picture.
What does follicular monitoring cost?
The cost of follicular monitoring depends on the number of scans required in a given cycle, whether blood hormone tests (such as oestradiol) are added alongside ultrasound, and the cycle type. See /costs-emi for current pricing information. A written estimate covering the monitoring component of your cycle is provided before any scans begin. Final cost depends on individual clinical evaluation. For overall treatment cycle pricing and EMI options, see costs & EMI.